OTC Markets OTCQX - Delayed Quote USD

Enzon Pharmaceuticals, Inc. (ENZN)

Compare
0.1200 -0.0049 (-3.92%)
At close: October 18 at 4:00 PM EDT

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current6/30/20243/31/202412/31/20239/30/20236/30/20233/31/2023
Market Cap 9.27M 13.36M 7.01M 6.94M 10.89M 14.84M --
Enterprise Value -36.96M -32.63M -40.00M -39.61M -35.25M -31.03M --
Trailing P/E 24.78 60.44 71.59 -- -- -- --
Forward P/E -- -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- -- --
Price/Sales 356.52 -- -- 267.03 418.69 570.88 742.15
Price/Book 3.05 4.06 2.00 2.76 3.99 4.83 --
Enterprise Value/Revenue -1.56k -- -- -- 319.22 460.77 569.11
Enterprise Value/EBITDA -- -- -- 183.40 156.65 97.59 97.14
3/31/2023 - 2/15/1984

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 6/30/2024

Profitability

Profit Margin 6,111.54%
Operating Margin (ttm) -1,250.00%

Management Effectiveness

Return on Assets (ttm) -1.46%
Return on Equity (ttm) 3.42%

Income Statement

Revenue (ttm) 26k
Revenue Per Share (ttm) 0.00
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) 314k
Diluted EPS (ttm) 0.0100
Quarterly Earnings Growth (yoy) 50.80%

Balance Sheet

Total Cash (mrq) 46.23M
Total Cash Per Share (mrq) 0.62
Total Debt (mrq) --
Total Debt/Equity (mrq) --
Current Ratio (mrq) 113.75
Book Value Per Share (mrq) 0.04

Cash Flow Statement

Operating Cash Flow (ttm) 1.37M
Levered Free Cash Flow (ttm) -729.5k

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52 Week Range 3 -14.29%
S&P 500 52-Week Change 3 39.07%
52 Week High 3 0.2400
52 Week Low 3 0.0600
50-Day Moving Average 3 0.1366
200-Day Moving Average 3 0.1170

Share Statistics

Avg Vol (3 month) 3 17.36k
Avg Vol (10 day) 3 10.35k
Shares Outstanding 5 74.21M
Implied Shares Outstanding 6 74.21M
Float 8 30.11M
% Held by Insiders 1 10.84%
% Held by Institutions 1 48.58%
Shares Short (5/13/2016) 4 259.38k
Short Ratio (5/13/2016) 4 1.71
Short % of Float (5/13/2016) 4 0.68%
Short % of Shares Outstanding (5/13/2016) 4 0.59%
Shares Short (prior month 4/15/2016) 4 298.38k

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 10/15/2019
Ex-Dividend Date 4 9/30/2019
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers